Ngā hua rapu kaituhi :: APM

1

Molecular basis of chronic granulomatous disease [see comments] mā Smith Rm, JT Curnutte

I whakaputaina 1991

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
2

Effects of anaerobiosis and inhibitors on O2-production by human granulocytes mā JT Curnutte, BM Babior

I whakaputaina 1975

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

Molecular basis of chronic granulomatous disease [see comments] mā RM Smith, JT Curnutte

I whakaputaina 1991

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Prolonged recombinant interferon-gamma therapy in chronic granulomatous disease: evidence against enhanced neutrophil oxidase activity mā RC Woodman, RW Erickson, Julie Rae, HS Jaffe, JT Curnutte

I whakaputaina 1992

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Absence of both the 91kD and 22kD subunits of human neutrophil cytochrome b in two genetic forms of chronic granulomatous disease mā CA Parkos, MC Dinauer, AJ Jesaitis, SH Orkin, JT Curnutte

I whakaputaina 1989

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Phosphorylation of the oxidase-related 48K phosphoprotein family in the unusual autosomal cytochrome-negative and X-linked cytochrome-positive types of chronic granulomatous diseas... mā Nobuyuki Okamura, S E Malawista, RL Roberts, Harvey M. Rosen, HD Ochs, BM Babior, JT Curnutte

I whakaputaina 1988

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i: